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Haematogenous metastasis is an important factor affecting the
prognosis of patients with colorectal cancer (Levin and Raijman,
1995). The attachment of circulating cancer cells to the vessel wall
in target organs is one of the earliest events initiating tumour
metastasis (Honn and Tang, 1992; Albelda, 1993; Gutman and
Fidler, 1995). Previous studies have demonstrated that the attach-
ment is mediated by various adhesion proteins, such as E-selectin
and its counter receptors, sialyl Lewis-x (sLe-x) and sialyl Lewis-
a (sLe-a), (Dejana et al, 1992; Takada et al, 1993; Irimura, 1994),
VLA-4-VCAM-1 (Rice and Bevilacqua, 1989; Martin-Pandura et
al, 1991), thrombospondin (Tuszynski et al, 1987; Walz, 1992),
CD44 variants (St John et al, 1990; Gunthert et al, 1991) and other
extracellular matrix (ECM) proteins (Humphries et al, 1986;
Iwamoto et al, 1987; Liotta, 1991).
Leucocyte infiltration in inflammatory tissue or homing to
lymphoid organs is a similar biological phenomenon as hematoge-
nous metastasis of cancer cells, in terms of the interaction with
local endothelium. The molecular mechanisms of the leucocyte
emigration have been extensively studied, and it has been gener-
ally accepted that the initial tethering and rolling are supported by
selectin-carbohydrate interactions, whereas integrins can not bind
to their ligands under shear flow conditions but function mainly at
the later steps (Butcher, 1991; Springer, 1994). In contrast to
leucocytes, the effect of shear stress has not been carefully evalu-
ated in the process of cancer cell attachment to vascular EC,
although some adhesion mechanisms seem to be shared with
cancer cells and leucocytes in static (Rice and Bevilacqua, 1989;
Takada et al, 1993). Here, in this study, we used a flow adhesion
assay system (Lawrence and Springer, 1991; Kitayama et al,
1997), and demonstrate that colon cancer cells tether, arrest and
spread on immobilized laminin (LM) under the continuous pres-
ence of shear flow and that the each step is mediated by different
LM receptors.
MATERIALS AND METHODS
Reagents, antibodies and preparation of adhesion
substrates
Fibronectin (FN), vitronectin (VN) and albumin (HSA) purified
from human serum, as well as LM purified from human placenta
were purchased from Calbiochem (La Jolla, CA, USA). These
ECM proteins were diluted to 10–50 mg ml–1 with phosphate-
buffered saline (PBS), pH 7.4. Then, 20 ml of these solutions were
spotted on polystyrene plates for 2 h at 37°C and blocked with
20 mg ml–1 HSA for more than 48 h.
Monoclonal antibodies (mAbs) to integrin a1 (HP2B6, mIgG1)
and  a6 (GoH3, rat IgG2a) were purchased from Immunotech
(Marseille, France). mAbs to a2 (P1H5, mIgG1) and a3 (P1B5,
mIgG1) were from Telios Pharmaceuticals (La Jolla, CA, USA).
Anti-b1 mAb (4B4, mIgG1) and control mouse-IgG1 or rat-IgG2a
were obtained from Coulter (Hialeah, FL, USA) and anti-b4 mAb
(UM-A9) was from Chemicon (Temecula, CA, USA). mAb to
67KD laminin receptor (MLuC5) was a generous gift from Dr
Silvie Menard (Milan, Italy). mAb to LM (HL-4H3) recognizing
P1 fragment of LM molecule was from Fuji Chemical Co.
(Takaoka, Japan).
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All the colon cancer cell lines, Colo201, Colo320, HT29, DLD-1
and WiDr were obtained from American Type Culture Collection
(ATCC, Rockville, MD, USA) and maintained in Dulbecco’s
modified Eagle’s medium (DMEM) with 10% fetal calf serum
(FCS). HT29, DLD-1 and WiDr were detached from plastic flasks
by the addition of 0.02% EDTA containing PBS + 0.25% trypsin,
washed twice and incubated for at least 1 h at 4°C before the
measurement of adhesion. All the cells were warmed up to 37°C
just before the experiments. HUVEC were isolated from normal
human umbilical cord and cultured as previously described
(Kitayama et al, 1997).
Laminar flow assay
A parallel-plate flow chamber (Kitayama et al, 1997) was mounted
on the coated substrates, and placed on the stage of a phase
contrast microscope and monitored with a 103 objective. Wall
shear stress was calculated as previously described (Lawrence and
Springer, 1991). The flow chamber and the optical area of the
microscope were covered with a plastic box and the temperature of
the inside was strictly maintained at 37°C. One million (1 ´ 106)
cells were suspended in 0.1 ml Hank’s balanced salt solution
(HBSS) with 10 mM HEPES (pH 7.4), kept at 4°C, and diluted
with 1.0 ml of 37°C assay medium (HBSS with 10 mM HEPES
including 2 mM calcium ion (Ca2+), 1 mM magnesium ion (Mg2+),
and 10% FCS, pH 7.4) just before the experiments. Then, the cell
suspensions were perfused on the substrates for 2 min through the
flow chamber using an automated syringe pump (Harvard
Apparatus, Natick, MA, USA) attached to the outlet side. For
blocking experiments, the mAbs were added to 1 ´ 106 cell
suspensions in 0.1 ml HBSS + HEPES, at a final concentration of
25 mg ml–1 in each mAb. After 1 h incubation on ice, the cells were
diluted with 1.0 ml assay medium and used for flow experiments.
Cells interacting with the substrate during flow were analysed
from the images videotaped with a TEC-470 CCD video camera
(Hamamatsu Photonics, Hamamatsu, Japan) and a Victor CVD-
1000 recorder. In some experiments, after 2 min perfusion of cell
suspension, the medium was perfused over the substrates for
another 30 min, and the change in shape of the attached cells was
monitored by videotape recorded in a time-lapse fashion.
Evaluation of tethering, spreading and statistics
Tethered cells were defined as cells that maintained an adhesive
interaction with the substrate for at least 1 second. The number of
attached cells was counted over the 2 min after the flow became
stable, and attached cells in three different fields were analysed.
Cells that did not spread on the substrates were detected as bright
cells with a round shape, whereas spread cells were observed as
dark and enlarged figures under the phase contrast microscope.
Thus, the two cell types were easily distinguished on the monitor
screen. The P-values were calculated by paired Student’s t-test and
differences with P < 0.05 were considered to be significant.
Immunohistochemistry
Frozen tissue sections of human normal liver were obtained from
the donor for liver transplantation operation performed in the
Hospital of the University of Tokyo. The sections were fixed with
acetone and incubated with 5 mg ml–1 of anti-LM mAb. Then, the
reaction was carried out using ABC kit (Vector Laboratories,
Burlingame, CA, USA) and peroxidase was developed with
diaminobenzidine (DAB) and hydrogen peroxide (H2O2). The
sections were counterstained with haematoxylin. For examination
at higher magnifications, the sections were stained with the anti-
LM mAb and fluorescein conjugated anti-mouse IgG, and
observed with a confocal laser microscope (Fluoroview, Olympus,
Tokyo, Japan).
RESULTS
Immobilized laminin supports tumour cell adhesion
under shear flow
Extracellular matrix proteins, FN, LM and VN were coated on
plastic plates at 10 mg ml–1, and the adhesiveness of the colon
cancer cells was examined under shear flow. At the shear of
1.0 dyn cm–2, only a few cancer cells bound to FN and VN as well
as control HSA. However, a considerable number of cells tethered
and accumulated on LM coated at the same condition in all five
cell lines (Figure 1A). The number of tethering Colo201 was
largely decreased as the shear increased more than 1.5 dyn cm–2,
and no cells tethered at 3.0 dyn cm–2 (Figure 1B). When the
concentration of coating substrates was increased to 50 mg ml–1,
the number of Colo201 bound on LM increased almost as twice in
each shear condition, whereas tetherings to FN and VN were
negligible (Figure 1B). Interestingly, the majority of Colo201 teth-
ered to LM did not roll but arrested immediately after the initial
contact with LM, that was a marked contrast to leucocytes
rolling on selectin substrates (Figure 2). Under the shear above
2.0 dyn cm–2, some of the tethered Colo201 rolled for a short
distance but detached to the flow stream in a few seconds, and thus
no cells showed continuous rolling on LM. Other four cancer cells
showed similar adhesion behavior as Colo201 (data not shown).
Tethered colon cancer cells spread on immobilized
laminin within minutes
After the attachment assay, the tethered and arrested cells on LM
were subsequently subjected to continuous shear flow with
warmed medium, and the shape change was observed for an addi-
tional 30 min. As shown in Figure 3, most of the tethered DLD-1
and HT29 cells were spread and flattened within the following
10–15 min under the continuous presence of 1.0 dyn cm–2 shear.
Colo201 usually grew at non-adhesive fashion under static culture
condition. However, approximately 90% of Colo201 tethered on
LM were flattened within the following 30 min under the same
shear flow.
Tethering and spreading on LM is partially mediated by
a6b1 and a6b4 integrins
Many molecules, such as integrins and carbohydrates, are identi-
fied as receptors for LM (Mecham, 1991). Among the integrins,
a1b1 (Hall et al, 1990), a2b1 (Elices and Hemler, 1989; Languino
et al, 1989; Lotz et al, 1990), a3b1 (Gehlsen et al, 1992), a6b1
(Sonnenberg et al, 1988; Lotz et al, 1990) and a6b4 (Lotz et al,
1990; Lee et al, 1992) integrins have been reported to mediate
binding to LM in static condition. To determine which integrins
function in flow condition, we examined the adhesion behaviour
1928 J Kitayama et al
British Journal of Cancer (1999) 80(12), 1927–1934 © 1999 Cancer Research Campaignof Colo201 pretreated with functionally blocking mAbs to these
integrins. As shown in Table 1, the number of tethering Colo201
was partially reduced to 60% (P < 0.05, n = 4) by the pretreatment
with anti-a6 integrin mAb (GoH3). None of the mAbs to a1, a2
and  a3 chains decreased the number of tethering Colo201.
Moreover, none of the three mAbs induced further inhibitory
effects of anti-a6 integrin mAb when used together with the mAb.
Similarly, anti-b4 integrin mAb and anti-b1 integrin mAb alone
showed no significant inhibition. However, when anti-b1 and anti-
b4 mAbs were used together, the tethering of Colo201 was signif-
icantly inhibited to the same level as anti-a6 mAb (69% of control,
P < 0.01, n = 4). This inhibition was specific since the addition of
the same concentration of control mouse-IgG1 (50 mg ml–1) have
no significant effects. Neither anti-b1 nor anti-b4 augments the
inhibitory effect of anti-a6 even when used together (data not
shown). This suggests that the tethering of Colo201 to LM is
partially mediated by both a6b1 and a6b4. However, neither anti-
b1 nor anti-b4 mAbs alone produced any significant inhibition
even used at the concentration of 100 mg ml–1 (data not shown).
The effects of these mAbs on cell spreading were contrasted.
Eighty-eight per cent of tethered Colo201 were flattened on LM
after 30 min perfusion. Anti-a6 mAb, that partially reduced teth-
ering cells, also significantly decreased the percentage of spread
cells. The percentages of spread cells in total tethers of anti-a6
treated Colo201 was 61% (75% of control, P < 0.05, n = 4). Anti-
a2 mAb, although showed no effect on tethering, strongly
decreased the spreading of Colo201 to 38% (43% of control, P <
0.05, n = 4). Moreover, if anti-a2 mAb was used with anti-a6
mAb, the spreading rate was further decreased to 18% (20% of
control, P < 0.05, n = 4). Anti-b1 integrin effectively inhibited the
spreading of Colo201 to 15% (17% of control, P < 0.01, n = 4),
that was almost the same level as when anti-a2 and anti-a6 mAbs
were used together. In contrast, mAbs to a1 and a3 integrins
showed no significant effect on spreading whether used alone or
together with anti-a6 mAb. When Colo201 were pretreated with
anti-b4 and anti-b1 mAbs, the percentages of spreading were at
the similar level as Colo201 treated with anti-b1 alone (16 ± 6.7%
Colon cancer cell adhesion to laminin in shear flow 1929
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Figure 1 Tethering activity of colon cancer cells on immobilized ECM
proteins. Fibronectin (FN), vitronectin (VN), laminin (LM) and human serum
albumin (HSA) were immobilized at the concentration of 10 mg ml–1 (A, B) or
50 mg ml–1 (B) as described in Materials and Methods. One million of
Colo201, Colo320, HT29, DLD-1, WiDr suspended in 1.0 ml of assay
medium were perfused on these substrates for 2 min at 1.0 dyn cm–2 (A) or
various shears (B), and the number of cells accumulated in three different
areas was counted at the end of perfusion under a microscope in each
experiment. Each value is mean ± s.d. of three different experiments
Figure 2 Post-tethering behaviour of PMN on E-selectin (1 mg ml–1) (A) and
Colo201 on LM (10 mg ml–1) (B) under the shear of 1.0 dyn cm–2. Five
consecutive images were captured every 2 seconds and superimposed with
imaging analyser software (Adobe Premier, with a Macintosh computer). With
flow from left to right, PMN rolled on E-selectin with a mean velocity of
13.7 mm per s, that was detected as five bright spots located linearly.
Whereas none of the tethering Colo201 were displaced more than 1 cell
diameter in the 10 seconds
A
Bvs 15 ± 8.1%, P > 0.05, n = 4). The anti-b4 mAb did not augment
the inhibitory effect of anti-a6 mAb on Colo201 spreading when
used together (data not shown). Those data indicate that the step of
cell spreading is mainly mediated by a2b1 and a6b1 integrins and
suggest that a6b4 integrin does not have a major role for this step.
Many Colo201 still tethered on LM even after the blocking of all
these integrins. No cells tethered on LM when Ca2+ was depleted
from the assay medium by the addition of 0.02% EDTA. At 4°C,
however, 46% of Colo201 examined at 37°C still tethered on LM
(Table 1). This strongly suggests that another non-integrin receptor
is involved in the tethering to LM. A 67 kDa monomeric polypep-
tide was reported to be a high affinity laminin receptor (Rao et al,
1983). Then, we used the functionally blocking mAb to the 67 kDa
laminin receptor (MLuC5) (Van den Brule et al, 1996) for this
flow experiment. However, the mAb did not show any inhibitory
effects on Colo201 tethering whether used alone or with anti-a6
mAb (Table 2).
Colon cancer cells did not tether on resting HUVEC but
did tether on intercellular LM
Colo201 were perfused on HUVEC monolayer cultured on LM.
As shown in Figure 4A, only a few cells tethered on resting
HUVEC with confluent state. When the cells were perfused on
sub-confluent HUVEC, few cells attached on HUVEC, while
many cells tethered and accumulated at the intercellular gap area
where the precoating of LM was supposed to be exposed to
flowing cells (Figure 4B). This was confirmed by the fact that the
accumulation was partially decreased by anti-a6 integrin mAb
(Figure 4A).
LM is abundantly expressed in endothelial cells of
small portal and hepatic veins of human liver
LM mainly exists in the subendothelial basement membrane
(Chung et al, 1979; Timpl et al, 1979), but it is not clear whether a
considerable amount of LM exists in the area exposed to blood
flow under physiological conditions. We tried the immunohisto-
chemical staining of normal human liver tissue with anti-LM mAb
recognizing the P1 epitope (Fujimoto, 1990). In addition to the
connective tissue of Glisson, EC of the portal and central vein
were strongly stained with anti-LM mAb (Figure 5 A,B).
Sinusoidal EC were only partially stained by anti-LM mAb. This
suggests the possibility that LM molecules are also expressed in
the luminal side of small portal and hepatic veins.
1930 J Kitayama et al
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Figure 3 Spreading of tethered cells on LM. Three colon cancer cells were
perfused on immobilized LM (10 mg ml–1) at 1.0 dyn cm–2 for 2 min. Then,
perfusion of the chamber was continued with warmed assay medium at the
same speed for another 30 min, and the shape changes of the tethered cells
were monitored on a screen. Total tethers were counted at the time points of
2 min after the initiation of perfusion. Then, all the tethered cells at the time
points were marked on screen and whether the cells spread or remained as
round shape within another 30 min was examined in each tether. The cells
tethered after 2 min were neglected in this analysis. Data are mean ± s.e.m.
of two separate experiments
Table 1 Inhibition of tethering and spreading of Colo201 on LM in shear
flow
No treatment Total tethers Percentage of spread cell
(cells/field)a (%)b
(–) 127 ± 45 (100%) 88 ± 10 (100%)
Anti-a1 136 ± 32 (> 100%) 88 ± 16 (100%)
Anti-a2 130 ± 22 (> 100%) 38 ± 16 (43%)c
Anti-a3 130 ± 13 (> 100%) 86 ± 16 (98%)
Anti-a6 76 ± 20 (60%)c 61 ± 16 (75%)c
Anti-b1 121 ± 41 (95%) 15 ± 8.1 (17%)d
Anti-b4 118 ± 23 (93%) 88 ± 9.1 (100%)
Anti-a1+anti-a6 84 ± 14 (63%)c 60 ± 4.4 (68%)c
Anti-a2+anti-a6 80 ± 7.5 (66%)c 18 ± 2.2 (20%)c
Anti-a3+anti-a6 90 ± 11 (71%)c 51 ± 6.4 (60%)c
Anti-b1 +anti-b4 88 ± 37 (69%)d 16 ± 6.7 (18%)d
Control mouse IgG1 132 ± 29 (> 100%) 89 ± 2.5 (> 100%)
Control rat IgG2a 144 ± 48 (> 100%) 90 ± 5.8 (> 100%)
Control mouse IgG1e 142 ± 20 (> 100%) 86 ± 3.8 (98%)
(50 mg ml)1
Control mouse IgG1 + 124 ± 48 (98%) 92 ± 5.8 (> 100%)
rat IgG2a
4°C 59 ± 18 (46%)d 0 (0%)d
0.02% EDTA 0 (0%)d 0 (0%)d
Colo201 cells treated with each mAbs at the concentration of 25 mg ml–1 (or
50 mg ml–1)e as described in Materials and Methods were perfused for 30 min
in 1.0 dyn cm–2. EDTA was used at a final concentration of 0.02%. In the
experiments at 4°C, the flow chamber and LM-coated plate as well as the
assay medium were cooled with ice before perfusion. aThe number of
tethered cells per field at 2 min after the initiation of perfusion. bThe number
of spread cells/total tethers at the end of perfusion. Each value is mean ± s.d.
of four different experiments. Quoted numbers show the relative percentages
to control without any treatment. cP < 0.05, d P < 0.01.
Table 2 Effect of mAb to 67KD LR on Colo201 tethering on LM in shear
flow
No Treatment Total tethers
(cells/field)
(–) 174 ± 22 (100%)
Anti-67KD LR 180 ± 41 (>100%)
Anti-a6 15 ± 29 (65%)a
Anti-a6+anti-67KD LR 131 ± 19 (75%)a
Colo201 cells treated with each mAbs at the concentration of 25 mg ml–1 were
perfused and analysed as Table 1. Each value is mean ± s.d of three different
experiments. aP < 0.05.DISCUSSION
The lodgement of circulating cancer cells in the vascular bed of
secondary organ is an essential step in metastatic process. This
attachment must occur in the continuous presence of shear stress,
similar to leucocyte tethering and rolling on inflammatory
endothelium. In this study, we used five colon cancer cell lines as
the models for liver metastasis of colon cancer. All the cell lines
were established from human colon cancer tissues and had
metastatic potential when injected intravenously. Here, we
observed that all the five colon cancer cells tethered on immobi-
lized LM substrate under physiological shear condition. Moreover,
those tethered cells arrested immediately and spread within
minutes order after the initial contact with LM. Tözeren et al
(1994) has already reported that human epithelial and carcinoma
cells tethered and rolled on the LM in the presence of laminar flow
possibly through a6b4 integrin. In that study, they used relatively
higher shear condition (> 3.5 dyn cm–2) and described that the teth-
ering cells rolled at the comparable velocity to that of leucocytes
on P-selectin (Lawrence and Springer, 1991). In our study,
however, all the tethering cancer cells did not roll but abruptly
arrested at the shear below 1.5 dyn cm–2. The ‘rapid sticking’ is
specific for LM substrates, since these cancer cells showed rolling
on E-selectin substrates (data not shown). Some tethers rolled for
several seconds before the detachment to the flow at higher
shear conditions, and no cells tethered under the shear above
3.0 dyn cm–2 even the LM was coated at very high concentration.
The exact reason of the difference between these two studies is not
clear, but supposed to be attributed to many differences in experi-
mental condition. One possible explanation is that LM purified
from Englebreth–Holm–Swarm tumour used in the previous study
has some differences in molecular structure from placenta-derived
LM in ours. The difference in LM coating efficiency between on
glass and on polystyrene may be related with the discrepancy.
However, the adhesion pattern we observed in this study has
already been described in mononuclear cells or eosinophils
perfused on purified VCAM-1, MAdCAM-1, or activated
HUVEC monolayer (Luscinskas et al, 1994; Alon et al, 1995;
Colon cancer cell adhesion to laminin in shear flow 1931
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Figure 4 Tethering of Colo201 to HUVEC or LM coated on plastic plates.
Half million (5 ´ 105) or 5 ´ 104 HUVEC were cultured on plastic plate (60
mm diameter) coated with LM (10 mg ml–1). Two days later those HUVEC
became confluent or sub-confluent state respectively. On these HUVEC
monolayers, Colo201 cells were perfused as in Figure 1, and the tethered
cells on HUVEC or at the bare area without HUVEC were separately counted
in three different fields. mAb treatment was performed as Table 1. Data are
mean ± s.d. in a representative experiment. *P < 0.05, n = 3. (B) Image at
the end of perfusion on subconfluent HUVEC. Most of the Colo201 cells that
tethered and arrested in flow were detected at the bare area between each
HUVEC but not on the HUVEC
A
B
Figure 5 Endothelial cells of small portal and hepatic veins in human liver
abundantly expressed LM molecule. (A) Frozen sections of normal liver were
stained with anti-LM mAb (HL-4H3) using ABC method and DAB
development. (´ 400). (B) The same sections were stained with FITC-
labelled secondary mAb, and observed with a confocal laser microscope
(Left: under fluorescein beam, Right: under normal light) (´ 1400). Cytosol of
small portal vein EC was brightly stainedBerlin et al, 1995; Kitayama et al, 1997). Those studies have
shown that the rapid sticking is mediated by a4 integrins, and
suggested that a4 integrin can immediately form tighter bonds
than selectins that are strong enough to be resistant to the contin-
uous shear force. Our data suggest that the cancer cells utilize
certain adhesion receptors for LM that has similar kinetics in bond
formation as a4 integrin. If the LM mediate the rolling interaction
as described by Tozeren et al (1994) cancer cells require another
factor to support cell arrest for metastasis formation. However, our
finding suggests a possibility that a single cancer cell circulating in
blood can develop metastasis only through the interaction with
LM.
LM is one of the most abundant constituents of the basement
membrane and regulates cell–ECM interactions such as adhesion,
migration, growth and differentiation in various cell types (Chung
et al, 1979; Timpl et al, 1979). The receptor for LM is not fully
characterized yet. Integrins are the major receptors for ECM
proteins. VLA-1 (a1 b1), VLA-2 (a2 b1), VLA-3 (a3 b1),
VLA-6 (a6 b1), VLA-7 (a7 b1) and a6 b4 integrins have been
reported to bind LM (Mecham, 1991). Our blocking experiments
using Colo201 showed that tethering to LM was partially inhibited
by anti-a6 mAb. Anti-b1 and anti-b4 mAbs alone showed no
significant effect on tethering. The blocking results are totally
consistent with the previous results by Tözeren et al (1994). In that
work, however, they showed that cells expressing integrin b4
chain bound to LM in flow while cells lacking b4 integrin did not
have any affinity to LM, and thus concluded that the tethering to
LM was dependent on a6b4. In this study, however, we used anti-
b1 and anti-b4 mAbs together, and found that they produced the
same level of inhibition as anti-a6 mAb. This suggests that a6b1
as well as a6b4 have a contribution on Colo201 tethering on LM.
The reason why either mAb alone did not show significant effect
may be explained by that the contributions of each integrin on
Colo201 tethering are too small to be recognized by the blockade
of each integrin alone.
Total blockade in a6b1 and a6b4 integrins did not lead the
complete inhibition in Colo201 tethering. The tethering to LM was
totally blocked by Ca2+ depletion, whereas some still tethered at
4°C condition (46% of control). From these data, it is unlikely that
other LM binding integrins such as a7b1 (Kramer et al, 1991) play
roles in Colo201 tethering, since all the integrin mediated adhesion
should be abolished at 4°C. Then, we asked the contribution of a 67
kDa monomeric polypeptide reported as a high affinity laminin
receptor (Rao et al, 1983). The expression of this receptor or its
precursor on cancer cells has been reported to be correlated with
malignant potential in various cancers, and induction of this
67 kDa receptor was reported to induce metastatic potential in non-
metastatic counterparts (Castronovo et al, 1989; Coice et al, 1991;
Van den Brule et al, 1996; Viacava et al, 1997). Although, the mAb
to 67 kDa LM receptor partially inhibited the Colo201 adhesion to
LM under static conditions (Viacava et al, 1997), it showed no
significant inhibition in Colo201 tethering. Galectins have been
reported to function as laminin receptors (Barondes et al, 1994; Van
den Brule et al, 1995). However, the galectins are unlikely to
mediate tethering under the flow condition, since the depletion of
Ca2+ with EDTA totally abolished the Colo201 tethering. Those
data suggest that other uncharacterized laminin receptors partici-
pate in the colon cancer cell tethering in shear flow.
Another new finding in our study is that most of the tethering
cancer cells were flattened within minutes’ order when the shear
flow was continuously subjected. Furthermore, the effects of anti-
integrin mAbs on cell spreading were contrasted from those on
tethering. The percentages of spread Colo201 in total tethers were
significantly inhibited by anti-a6 and more strongly by anti-a2
mAbs, although the latter mAb showed no effect on Colo201 teth-
ering. More than 80% of spreading was abolished by anti-b1 mAb.
The effect of anti-a2 plus anti-a6 was additive and almost equal to
anti-b1 integrin. In contrast, anti-b4 did not show clear effect to
enhance the inhibitory effect of anti-b1 mAb even when used with
anti-b1. No cells spread at 4°C. Those data clearly indicate that the
post-tethering spreading on LM is mostly mediated by a2b1 and
a6b1 integrins, while a6b4 did not have major role for cell
spreading. In other words, colon cancer cells partially change the
receptor usage from tethering to spreading on LM.
Recently, it has been shown that laminin have various isoforms,
and each of them has specificity in its receptor usage, kinetics
for adhesion function, and tissue distribution (Rousselle and
Aumailley, 1994; Timpl and Brown, 1994; Tani et al, 1996). In
particular, laminin 5 has been shown to mediate strong adhesion of
various cell types including colon cancer cells mainly through
a3b1 integrin (Rousselle and Aumailley, 1994; Orian-Rousseau et
al, 1998). In our study, mAb to a3 showed no significant effect
both on tethering and spreading of Colo201. However, the laminin
we used in this study was purified from placenta that was
consisted mainly of laminin 1, and thus the precise role of a3b1
integrin for metastasis formation needs to be investigated using
purified form of laminin 5.
From our results, we can speculate two possible situations that
the LM molecule function as tethering molecule for cancer metas-
tasis (Figure 6). Although LM mainly exists at basement
membrane, the subendothelial LM molecule can be exposed to
blood flow when EC are damaged and detached from the basement
membrane. In this situation, the LM molecule is supposed to trap
the circulating cancer cells even in blood flow that results in the
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Figure 6 Possible situations when LM functions as tethering molecule for
cancer cells. (A) Subendothelial LM molecule is exposed to blood flow where
EC are damaged and detached from the basement membrane. (B) LM was
produced, bound to LM receptors, and presented on the luminal surface of
certain EC. †: LM molecule, // and m: LM receptors, EC: endothelial cellmetastasis formation in those areas (Figure 6A). Animal studies
have shown that endothelial injury by drug (Orr et al, 1986),
hyperoxia (Adamson et al, 1987), radiation (von Essen, 1991), or
activated leucocytes (Orr and Warner, 1987) significantly
promotes local arrest and metastasis in the lung. We found that
Colo201 cells, if perfused on sub-confluent HUVEC, preferen-
tially tethered at the bare area as shown in Figure 4B. From this
finding, the preferential deposition of tumour cells in EC denuded
areas in those animal studies is considered to be mediated through
LM molecule.
Another possibility is that LM may be expressed on the luminal
surface of EC in certain organs. Some EC have been shown to
produce LM (Gospodarowicz et al, 1981; Tokida et al, 1990). Our
staining experiment clearly showed that portal and hepatic veins in
the normal liver strongly expressed LM molecules in their cytosol.
In these vessels, therefore, LM is supposed to be presented on the
luminal surface, since microvascular EC were reported to express
LM receptors such as 67 kDa receptor or b1 integrins on their cell
surface membrane (Yannariello-Brown et al, 1988; Cheng and
Kramer, 1989). In fact, an electron microscopic study has demon-
strated that LM is present on the luminal surface of capillaries in
murine lung (Hilario et al, 1996). Those LM molecules can be
recognized by another LM receptor on cancer cells, and thus may
function as a tethering molecule in organ-specific metastasis
(Figure 6B).
In summary, colon cancer cells showed tethering, arrest and
subsequent spreading on immobilized LM under physiological
shear flow. The tethering was partially mediated by a6b1 and
a6b4, while the spreading was mostly by a2b1 and a6b1 inte-
grins. Although LM has been proposed to have a strong associa-
tion with the metastatic potential of various cancers (Hunt, 1989;
Liotta, 1991; Honn and Tang, 1992), our study further emphasizes
the role of this molecule in tumour metastasis. This interaction
seems to be especially important when the metastasis develops in
EC-damaged areas or in organs with LM-rich vessel system.
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